Unilever invests in molecular design innovation
Collaborates with BioLeap to develop consumer products
Unilever has entered into a partnership with BioLeap – a company specialising in molecular design technology – with a view to developing ‘superior’ consumer products. The two-year initiative will witness a team of scientists from Unilever and BioLeap joining forces to work on the core biology of ageing. Unilever hopes molecular design technology will enable it to build differentiated, health-enhancing products across several categories.
“This collaboration with BioLeap is another example of the commitment at Unilever to partner innovators from outside the business with specific biotech assets and knowledge with our own in house science and development experts based in our six core laboratories across the world,” commented Unilever’s chief R&D officer, Genevieve Berger.
“I see the key benefits of this collaboration with BioLeap being the development of superior products across a number of categories and exclusivity that will potentially give us competitive advantage in the marketplace.”